Oncotarget is a peer based research journal which covers research on the different aspects of oncology. It was established in 2010, and the renowned impact journals publish their work. Oncotarget journals are an open source since everyone is allowed to access them or even give submissions to aid in their research.In depth, Oncotarget focuses on the existence of cancer-based on pathological studies. Potential patients who are required to be subjected to therapies and methods of cancer treatment to be employed are also key issues explained in this journal. It also looks at the new therapeutic agents and their capacity to manage programs for the cancer patients.
This journal explores the origin of new therapies and also focuses on the existing ones. The journal explains how these therapies can be improved to ensure a positive outcome of the patient. Importantly, it reveals the usage of these treatments, the ultimate employment of them and the response given to the cancer patients as well as the medical professional.Under the ultimate management by experienced scientists in the medical fields, the journal has given a chance to all researchers to contribute to the progress of scientific data. The journal welcomes any submitted papers which cover the original research. Basic science, epidemiological science, clinical reviews, and evaluations have gotten a chance in the scientific research industry through Oncotarget.
Oncotarget has had the opportunity to submit journals based on blood and lymphatic cancers. In the identification of targets for therapies and optimizing the usage of integrated modes of treatment to optimize preventive measures and improve the survival of the patient. Oncotarget has been able to improve the quality of life for the patients. Their primary goal is to have a disease free world and most of their studies have been proven success by many scientific research institutions.The journal has also discussed the use of oncolytic viruses to treat cancer. This has emerged as a treatment method that uses the propagation of viruses which are competitive in the treatment of cancer. Identification of drugs that improve the production of viruses has acted as a new strategy to boost the use of oncolytic viruses. The firm has also been involved in research on breast cancer and gastrointestinal cancer.